AMR Therapeutics

Gen AI based Drug Discovery Platform

Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways or proteins. Generative AI models are developed taking into account comprehensive and unbiased data sets followed by in vitro validation.

insilico

insilico:

Virtual screening to identify target compounds through both ligand-based and structure-based approaches

invitro

invitro:

Leveraging extensive clinical metadata to screen and evaluate compounds and discovering new agents effective against microbial infections.

AMR Therapeutics

Gen AI based Drug Discovery Platform

Developing novel antimicrobial drugs, by a rational approach taking into account the mechanisms of Antimicrobial drug Resistance by targeting the pathways or proteins. Generative AI models are developed taking into account comprehensive and unbiased data sets followed by in vitro validation.

AMR Lab

State-of-the-Art Research for advanced solutions to contain Antimicrobial resistance

The AMR Lab is dedicated to advancing our understanding of AMR through cutting-edge research and innovation. Utilizing state-of-the-art technologies such as whole-genome sequencing, transcriptomics, and AI/ML analytics, the lab is focused on deciphering the mechanisms inorder to mitigate the impact of Antimicrobial resistance and support global healthcare community.

More Details
Linkedin Facebook X-twitter
  • Corporate Office
SCIINV Biosciences Private Limited Flat# 401, P No. 60 Abhis Hiranya Apartments, Kavuri Hills, Guttala Begumpet, HYDERABAD-500081, Telangana, India
  • R&D Center
SCIINV Biosciences Private Limited Room NO: 011, ASPIRE-BioNEST, 3rd Floor, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad-500046
Linkedin Facebook